Navigation Links
Patents in Medical News

90 Brain Fitness Patents for Posit Science

Rate of Invention in Applied Brain Science Continues to Accelerate SAN FRANCISCO, June 23 /PRNewswire/ -- Posit Science, the leading provider of brain fitness software, today announced that it was issued patent number 7,540,615 by the US Patent & Trademark Office. Posit Science now owns ...

Misonix Announces the Purchase of Patents From ProRhythm, Inc.

FARMINGDALE, N.Y., June 12 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON ), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, announced today that it has purchased th...

Orexigen(R) Therapeutics Announces In-Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave(R)

SAN DIEGO, June 11 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company focused on the treatment of obesity, today announced the licensing of certain intellectual property (IP) from GlaxoSmithKline (GSK) that expands the Company's IP position unde...

Impliant Granted Two New U.S. Patents and Successfully Defends European Patent Opposition Case

PRINCETON, N.J., June 9 /PRNewswire/ -- Impliant, Inc., a developer of novel spine arthroplasty alternatives to fusion surgery, today announced that the European Patent Office has confirmed the validity of one of its key patents following an Opposition by Archus Orthopedics, Inc. (Redmond, WA) tha...

CAP Joins Landmark Lawsuit Challenging Legality of Myriad Genetics Gene Patents

The College of American Pathologists today joined a lawsuit against the U.S. Patent and Trademark Office and Myriad Genetics, challenging the legality of Myriad's patents for the genes known as BRCA1 and BRCA2, which are indicators for hereditary predisposition to breast and ovarian cancer. ...

ACMG Joins Lawsuit Challenging Patents on Breast Cancer Genes; Genes Are Naturally Occurring Substances and Should Not Be Patented, Says American College of Medical Genetics

BETHESDA, Md., May 12 /PRNewswire-USNewswire/ -- The American College of Medical Genetics (ACMG) has joined the Association for Molecular Pathology, the College of American Pathologists, and the American Society for Clinical Pathology in a lawsuit filed today charging that patents on the human gen...

ACLU Challenges Patents on Breast Cancer Genes

Gene Patents Stifle Patient Access To Medical Care And Critical Research NEW YORK, May 12 /PRNewswire-USNewswire/ -- The American Civil Liberties Union and the Public Patent Foundation at Benjamin N. Cardozo School of Law (PUBPAT) filed a lawsuit today charging that patents on two human genes...

German Federal Patent Court Invalidates Wake Forest NPWT Patents Licensed to KCI

ST. PETERSBURG, Fla., March 17 /PRNewswire-FirstCall/ -- Smith & Nephew Inc.'s Advanced Wound Management division (LSE: SN; NYSE: SNN ) announced that the German Federal Patent Court in Munich has held the Wake Forest patent for negative pressure (NPWT) licensed to Kinetic Concepts, Inc. (...

Aribex(R) Awarded Patents for Handheld X-ray

OREM, Utah, Jan. 19 /PRNewswire/ -- Aribex, Inc., a world leader in handheld x-ray technologies, announced today that it has been allowed a second U.S. patent for its NOMAD Handheld X-ray System. The latest patent (Appl. # 20070269010) protects the central concept of having all components of...

U.S. Patent and Trademark Office Issues Mylan's Specialty Division, Dey L.P., Three Additional Patents Protecting Perforomist(R) Inhalation Solution

PITTSBURGH, Jan. 12 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Dey L.P. has been issued several additional U.S. patents protecting the company's Perforomist(R) Inhalation Solution, a chronic obstructive pulmonary disease (COPD) treatment. U...

Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company License to Certain Alzheimer's Patents and Patent Applications

NEW YORK, Jan. 7 /PRNewswire-FirstCall/ -- Intellect Neurosciences, Inc. ( OTC Bulletin Board: ILNS ), a biopharmaceutical company focused on development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease (AD), announced today that it has granted a non-...

Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company an Option to License Certain Alzheimer's Patents and Patent Applications

Agreement Follows Recent Grant by Intellect of License to Wyeth (NYSE: WYE) and Elan Pharma International Ltd. NEW YORK, Oct. 8 /PRNewswire-FirstCall/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), a biopharmaceutical company focused on development of disease-modifying therapeu...

U.S. District Court in Delaware Reinstates Damage Awards to Cordis Corporation on Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation

MIAMI, Sept. 15 /PRNewswire/ -- The U.S. District Court in Delaware today granted Cordis Corporation's motion for final judgment against Boston Scientific Corporation and Medtronic, Inc. in their cases involving the original Palmaz balloon expandable stent patent. Cordis had asked U.S. Distr...

TruFUSE(R) Patents Awarded

CLEARWATER, Fla., July 8 /PRNewswire/ -- minSURG(TM) Corporation, through its parent company, Orthopedic Development Corporation, has received a Notice of Allowance from the United States Patent and Trademark Office on two of its pending US patent applications. The patents protect the designs ...

Telik Announces Patents on Compounds Related to TELINTRA

PALO ALTO, Calif., June 10 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK ), announced today that the European Patent Office has issued notices of allowance for two applications covering new compounds related to one of Telik's lead clinical candidates, TELINTRA(R). Corresponding applicat...

Jury Validates Key Mannatech Technology Patents Involving Its Ambrotose(R) Glyconutrient Products

Glycoproducts International Inc., found to have committed patent and trademark infringement COPPELL, Texas, May 12 /PRNewswire-FirstCall/ -- Mannatech, Incorporated (Nasdaq: MTEX ) a leading developer and provider of dietary supplements and skin care solutions, today...

MMR Information Systems, Inc. Announces 250,000 Membership Milestone and Granting of International Patents

COMPANY ALSO ANTICIPATES MYMEDICALRECORDS PHR TO OFFER CCHIT MANDATED FEATURES LOS ANGELES, April 20 /PRNewswire-FirstCall/ -- MMR Information Systems, Inc. (OTC Bulletin Board: FVRL), which through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (collectively, "MMR") provides c...

United States Patent Office Rejects KCI's Patents

ST. PETERSBURG, Fla., Feb. 19 /PRNewswire-FirstCall/ -- Smith & Nephew's Advanced Wound Management division (LSE: SN; NYSE: SNN ) announced that the United States Patent and Trademark Office (Patent Office) has rejected as unpatentable three of KCI's negative pressure wound therapy (NPWT) pa...

ALSIUS CORPORATION PREPARED TO INVALIDATE ZOLL TEMPERATURE MANAGEMENT PATENTS

IRVINE, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Alsius Corporation (Nasdaq: ALUS ), the worldwide leader in intravascular temperature management (IVTM(TM)) therapies for critically ill patients, today announced that it is prepared to respond aggressively to the patent lawsuit brought against it...

U.S. Court of Appeals Rules That Smith & Nephew Does Not Infringe KCI Patents

ST. PETERSBURG, Fla., Feb. 2 /PRNewswire-FirstCall/ -- Smith & Nephew's Advanced Wound Management division (LSE: SN; NYSE: SNN ) today announced that the U.S. Court of Appeals for the Federal Circuit upheld a trial court judgment that the gauze-based Versatile 1 negative pressure wound the...

MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents

GERMANTOWN, Md., Nov. 6 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK ), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that three patents protecting Moxatag (amoxicillin extended-release) Tablets, ...

Court Rejects Two Medtronic Patents

Boston Scientific obligation reduced from $250 to $19 million NATICK, Mass., Aug. 29 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced that the U.S. District Court of Marshall, Texas found two patents of Medtronic, Inc. (NYSE: MDT ) unenforceable for i...

The Quantum Group Files Four Additional Patents

Company Expands IP Portfolio to Nine Filings, with Additional Applications Expected WELLINGTON, Fla., April 17 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (Amex: QGP, QGP.WSA, QGP.WSB) (http://www.QuantumMD.com ) announced today that it has filed four addit...

Neuralstem Responds to Incorrect StemCells, Inc. Release on Patents

ROCKVILLE, Md., April 15 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (Amex: CUR ) today responds to an earlier press release by StemCells, Inc. by stating that StemCells, Inc. has completely mischaracterized the meaning of the US Patent and Trademark Office's most recent action. (Logo: http...

Cyberonics Licenses Obesity-Related Patents

HOUSTON, Dec. 18 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) announced that effective December 18, 2007, the company has entered into an agreement with Ethicon Endo-Surgery granting exclusive rights to the company's patents and patent applications pertaining to vagus nerve stimul...

Start Licensing, Inc. Further Strengthens Position in Cloning Industry With New Patents

New Patents Announced for Methods of Cloning Livestock From Differentiated Donor Cells AUSTIN, Texas, Dec. 11 /PRNewswire-USNewswire/ -- Start Licensing, Inc. (Start) announced today that the U.S. Patent and Trademark Office has granted U.S. Patent Nos. 7,304,204 and 7,307,198 covering met...

US Denies Granting Patents on Yoga Postures

Amid a raging row in India over reported attempts to patent the ancient Indian practice of yoga overseas, the US denied granting patents on yoga positions. In the same breath, the US embassy said here that it has granted patents on "new and non-obvious devices that may be used in conjunction...

Dr Reddy’s Laboratories to challenge patents on drug

Pharma major Dr Reddy’s Laboratories will continue to aggressively challenge patents on drugs in the US despite the recent denial of a 180-day marketing exclusivity to its generic Omeprazole 40 mg capsules by the US Food and Drug Administration. Omeprazole is indicated for the treatment of duodenal...

People Before Patents

The Médecins Sans Frontière (MSF), a leading organization of conscientious and concerned doctors, has issued an alert about a lawsuit that the Swiss drugs firm//, Novartis, has brought against India, demanding a patent for one of its products (Gleevac, a leukemia drug). Critics say that drug f...

Thailand Backs Off Threat to Break Drug Patents

Thailand has delayed breaking the patent of an AIDS drug and a heart medicine, and entered into negotiations with drug firms// to lower the price so that more people can be treated. The negotiation panel of the Public Health Ministry yesterday (7 February) held its first talks with US firm Abbo...

Labopharm Reports Results for Second Quarter Fiscal 2009

...ted to sales and marketing and the accrual for the Company's share of litigation costs incurred by Purdue Pharma to enforce certain of Purdue's U.S. patents related to Labopharm's once-daily tramadol product. These were partially offset by lower costs for consultants and professional services, a reduction ...

NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions

...re businesses. " About NutraCea NutraCea is a world leader in production and utilization of stabilized rice bran. NutraCea holds many patents for stabilized rice bran production technology and proprietary neutraceutical formulas ranging from arthritis, chronic bowel conditions, and effective...

Transcept Pharmaceuticals to Report Second Quarter 2009 Results

... The FDA has established October 30, 2009 as its target date under PDUFA to take action on its review of the NDA. Transcept is actively pursuing patents to protect Intermezzo (R) in the United States and key non-U.S. markets, and, as part of the NDA submission, has requested that the FDA grant three y...

Winner Medical Schedules 2008/2009 Third Quarter Earnings Release on Tuesday, August 11, 2009

...100% natural cotton. The products are sold world-wide, with Europe, the US and Japan serving as the top three markets. The Company currently holds 50 patents and patent applications in various products and manufacturing processes and is one of the few Chinese companies licensed with the US Food and Drug Adm...

The Reduction of Eye Fatigue Improves Vision in Older Subjects

...reas of astaxanthin research that Fuji is actively supporting include cardiovascular, diabetes and metabolic syndrome. Fuji Chemical also holds seven patents for astaxanthin in human application as well as numerous pending patents. Fuji's AstaReal brand of astaxanthin is approved for use in nutritional supp...

ICBS to focus on pharmaceutical and environmental markets

...tions in the detection of Total Coliforms and E.coli to WHO standards using globally approved methods (USEPA, AWWA-APHA). The company holds world wide patents NB. This news release includes statements that constitute forward-looking statements. Please be aware that any such forward-looking statements ar...

Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers

...e competitive with its products. In addition, while Amgen routinely obtain patents for its products and technology, the protection offered by its patents and patent applications may be challenged, invalidated or circumvented by i...

AccuVein Vein Illuminator Receives European CE Mark

...ice miniaturization and user-intuitive design, the AV300 is the world's first portable, non-contact vein illumination solution. With more than a dozen patents filed worldwide, AccuVein demonstrates an ongoing commitment to invest in improving patient care and patient satisfaction. For more information...

Isis Pharmaceuticals to Present at Canaccord Adams' 29th Annual Global Growth Conference

...bbott, are commercializing. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,600 issued patents worldwide. Additional information about Isis is available at www.isispharm.com . ...

DURECT Corporation Announces Second Quarter 2009 Financial

... ORADUR(R) technology, which is covered by issued patents and pending patent applications owned by us...he referenced product candidates, avoid infringing patents held by other parties and secure and defend patents of our own, and manage and obtain capital to fund ...
Other Tags
(Date:11/18/2014)...   News Highlights: ... The Partners Data Lake, an agile data and ... will allow researcher and clinicians to explore and ... lives of patients , The Partners Data ... the Partners system, breaking down physical barriers for ...
(Date:11/18/2014)... 2014   EyeLock Inc. , a market ... MorphoTrust USA (Safran), a leading U.S. provider ... strategic partnership to offer comprehensive biometric identity solutions ... airport screening and financial services markets. ... consumers through a nationwide network of 1,100 IdentoGO® ...
(Date:11/12/2014)... 2014 Crossmatch™, a leading provider of biometric ... fingerprint readers have been deployed throughout Montparnasse Pasteleria, ... Mexico . The bakery chain implemented the Crossmatch ... caused by employees clocking in for each other. ... Montparnasse relied on paper timecards and a mechanical time ...
Breaking Biology News(10 mins):Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2
(Date:11/24/2014)... Recently, SweetDressy.com, a well-known dress supplier and ... of 2014 Evening Dresses. All these fresh items are ... marketing manager, the special offer is valid until Dec. ... Sweetdressy.com has been working well in the fashion industry ... designs. Their new dresses may be the best products ...
(Date:11/24/2014)... CA (PRWEB) November 24, 2014 SafeHandles™ ... episode of Innovations with Ed Begley Jr, airing via ... was created to provide a passive, non-invasive, replaceable, and ... how SafeHandles™ incorporates custom-fit shrinkable sleeves and adhesives to ... , “At the core of SafeHandles is the ...
(Date:11/23/2014)... The clinical trial report, "Aspergillosis Global ... the Aspergillosis clinical trial scenario. This report provides ... trials on Aspergillosis. It includes an overview of ... per the site of trial conduction across the ... disease clinical trials by their phase, trial status, ...
(Date:11/23/2014)... Pro Ace Care, a renowned Vancouver hot ... be providing an 8 year warranty on its selected hot ... went up due to the impending winter season, it was ... the premium service that the company provides. As a result, ... John Wood and Bradford hot water tanks. , “Every ...
(Date:11/23/2014)... Dallas, TX (PRWEB) November 23, 2014 ... the market such as its significance, programs and ... globally and Chinese suppliers major market gamers in ... company information, item specifications, prospective, manufacturing value, and ... statistical research, the evaluation symbolizes the globally and ...
Breaking Medicine News(10 mins):Health News:SweetDressy.com Unveiled A New Selection Of Evening Dresses 2Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 4Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 4
Other Contents